Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
about
The effect of tuberculosis treatment at combination antiretroviral therapy initiation on subsequent mortality: a systematic review and meta-analysisRoutine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.Predictors of Treatment Failure in HIV-Positive Children Receiving Combination Antiretroviral Therapy: Cohort Data From Mozambique and Uganda.HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and ZimbabweThe association between quality of HIV care, loss to follow-up and mortality in pediatric and adolescent patients receiving antiretroviral therapy in NigeriaHIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periodsPrognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programsT-Cell Subsets Predict Mortality in Malnourished Zambian Adults Initiating Antiretroviral Therapy.Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort studyThe virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data.Implementation of antiretroviral therapy guidelines for under-five children in Tanzania: translating recommendations into practice.Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.Meningitis in HIV-positive patients in sub-Saharan Africa: a review.Management of severe non-TB bacterial infection in HIV-infected adults.Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.Survival of HIV-1 vertically infected children.Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.HIV and new onset seizures: slipping through the cracks in HIV care and treatment.Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.The Continuum of HIV Care in Rural Mozambique: The Implications of HIV Testing Modality on Linkage and Retention.Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria.Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIVLate Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY TrialCauses and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY TrialManaging Advanced HIV Disease in a Public Health Approach
P2860
Q27014121-80442E05-ABA8-4144-87CA-7D421FD1A859Q30539434-99949E28-AE3A-459B-9A58-BA1157261CB0Q30558310-D219F99F-7593-46F8-B404-2D533550C8A8Q30997469-6338CA44-4A0D-443E-8E5C-C6F8409E0A26Q33713765-DF591B7C-E555-42CC-86C0-DA13F5053680Q33974971-DC945507-F67F-4278-8D24-43D356D1D9F2Q34081657-08E81897-00E1-4E67-8809-5D06C50124E8Q35148237-87C2221F-15F9-4558-AA0A-55DD1015DE12Q35666026-835585E9-7C5B-4DCA-809E-395F90BB5A47Q35779587-95D21E33-B629-4718-8C72-0E9BE69F3E55Q36286733-B8D64A59-6034-4FA8-955B-ABFC393C8CE9Q36389935-9B980E11-5BBF-4DEE-BD9F-AD0BE9522E65Q37033083-142CF2E5-1723-4A89-8188-0020873213EEQ38259519-571B0850-AF6D-430D-8625-9139797279C8Q38314390-F05EC635-C01F-45B2-A212-E28E36CE7A96Q38849598-1E603B21-1BD7-4A6A-9951-49CF10E1B755Q38975088-35E1DA64-91E9-4F8E-8207-44252B9396A7Q39346449-1AFA869A-63FA-4B01-9E60-2FF3B9F852B2Q39413554-C84F6C6C-E007-4D4B-8AA6-E023AF14A723Q40708664-53F15BEE-1ACA-4666-B7DA-2A1C2BB03B8BQ52589311-AE0B7E9C-5904-4A46-9F51-67294C7AEE70Q53818455-BB3A3C34-974F-4518-B03A-CD4587BF7505Q53840216-D1E1776E-1EE4-4B5C-9E0D-E31AC068BB74Q54260534-9FD26656-A08B-46F1-B76C-F84B28D1CD14Q56910418-494FE3BB-BC12-45A5-B0F4-4711F9C7473EQ56912547-390D19BB-1F7B-4932-967A-FE99F120E60AQ56912555-DB39B1A9-0FBE-4961-9CB5-FB8CB332FFDCQ56927385-F39C3CDA-1DA3-46BB-A561-3555881C1307
P2860
Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mortality in the year followin ...... ildren in Uganda and Zimbabwe.
@ast
Mortality in the year followin ...... ildren in Uganda and Zimbabwe.
@en
type
label
Mortality in the year followin ...... ildren in Uganda and Zimbabwe.
@ast
Mortality in the year followin ...... ildren in Uganda and Zimbabwe.
@en
prefLabel
Mortality in the year followin ...... ildren in Uganda and Zimbabwe.
@ast
Mortality in the year followin ...... ildren in Uganda and Zimbabwe.
@en
P2093
P2860
P921
P356
P1476
Mortality in the year followin ...... ildren in Uganda and Zimbabwe.
@en
P2093
A Sarah Walker
Addy Kekitiinwa
Andrew J Prendergast
Cissy Kityo
DART and ARROW trial teams
Diana M Gibb
James Hakim
Kusum Nathoo
Patricia Nahirya-Ntege
Paula Munderi
P2860
P304
P356
10.1093/CID/CIS797
P407
P577
2012-09-12T00:00:00Z